125 related articles for article (PubMed ID: 38754459)
1. Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial.
Idro R; Ogwang R; Anguzu R; Akun P; Ningwa A; Abbo C; Giannoccaro MP; Kubofcik J; Mwaka AD; Nakamya P; Opar B; Taylor M; Nutman TB; Elliott A; Vincent A; Newton CR; Marsh K
Lancet Glob Health; 2024 Jul; 12(7):e1149-e1158. PubMed ID: 38754459
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline for the treatment of nodding syndrome (DONS); the study protocol of a phase II randomised controlled trial.
Idro R; Anguzu R; Ogwang R; Akun P; Abbo C; Mwaka AD; Opar B; Nakamya P; Taylor M; Elliott A; Vincent A; Newton C; Marsh K
BMC Neurol; 2019 Mar; 19(1):35. PubMed ID: 30841858
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic malaria parasitaemia and seizure control in children with nodding syndrome; a cross-sectional study.
Ogwang R; Anguzu R; Akun P; Ningwa A; Kayongo E; Marsh K; Newton CRJC; Idro R
BMJ Open; 2018 Oct; 8(10):e023624. PubMed ID: 30341136
[TBL] [Abstract][Full Text] [Related]
5. Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control study.
Ogwang R; Muhanguzi D; Mwikali K; Anguzu R; Kubofcik J; Nutman TB; Taylor M; Newton CR; Vincent A; Conroy AL; Marsh K; Idro R
Epilepsia Open; 2021 Jun; 6(2):297-309. PubMed ID: 34033255
[TBL] [Abstract][Full Text] [Related]
6. Nodding syndrome may be an autoimmune reaction to the parasitic worm
Johnson TP; Tyagi R; Lee PR; Lee MH; Johnson KR; Kowalak J; Elkahloun A; Medynets M; Hategan A; Kubofcik J; Sejvar J; Ratto J; Bunga S; Makumbi I; Aceng JR; Nutman TB; Dowell SF; Nath A
Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202777
[TBL] [Abstract][Full Text] [Related]
7. Nodding syndrome (NS) and
Lagoro DK; Arony DA
Pan Afr Med J; 2017; 28():1. PubMed ID: 29138647
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Gao L; Li Y; He P; Chen Z; Yang H; Li F; Zhang S; Wang D; Wang G; Yang S; Gong L; Ding F; Ling M; Wang X; Ci L; Dai L; Gao GF; Huang T; Hu Z; Ying Z; Sun J; Zuo X
Lancet Child Adolesc Health; 2023 Apr; 7(4):269-279. PubMed ID: 36803632
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
10. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
11. Is nodding syndrome an Onchocerca volvulus-induced neuroinflammatory disorder? Uganda's story of research in understanding the disease.
Idro R; Opar B; Wamala J; Abbo C; Onzivua S; Mwaka DA; Kakooza-Mwesige A; Mbonye A; Aceng JR
Int J Infect Dis; 2016 Apr; 45():112-7. PubMed ID: 26987477
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis for leptospirosis.
Win TZ; Perinpanathan T; Mukadi P; Smith C; Edwards T; Han SM; Maung HT; Brett-Major DM; Lee N
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD014959. PubMed ID: 38483067
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
Pollard AJ; Launay O; Lelievre JD; Lacabaratz C; Grande S; Goldstein N; Robinson C; Gaddah A; Bockstal V; Wiedemann A; Leyssen M; Luhn K; Richert L; Bétard C; Gibani MM; Clutterbuck EA; Snape MD; Levy Y; Douoguih M; Thiebaut R;
Lancet Infect Dis; 2021 Apr; 21(4):493-506. PubMed ID: 33217361
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.
Debrah AY; Specht S; Klarmann-Schulz U; Batsa L; Mand S; Marfo-Debrekyei Y; Fimmers R; Dubben B; Kwarteng A; Osei-Atweneboana M; Boakye D; Ricchiuto A; Büttner M; Adjei O; Mackenzie CD; Hoerauf A
Clin Infect Dis; 2015 Aug; 61(4):517-26. PubMed ID: 25948064
[TBL] [Abstract][Full Text] [Related]
16. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of inhaled IBIO123 for mild-to-moderate COVID-19: a randomised, double-blind, dose-ascending, placebo-controlled, phase 1/2 trial.
Maranda B; Labbé SM; Lurquin M; Brabant P; Fugère A; Larrivée JF; Grbic D; Leroux A; Leduc F; Finzi A; Gaudreau S; Swart Y;
Lancet Infect Dis; 2024 Jan; 24(1):25-35. PubMed ID: 37619584
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial.
Costa ACS; Brandão AC; Boada R; Barrionuevo VL; Taylor HG; Roth E; Stasko MR; Johnson MW; Assir FF; Roberto MP; Salmona P; Abreu-Silveira G; Bederman I; Prendergast E; Hüls A; Abrishamcar S; Mustacchi Z; Scheidemantel T; Roizen NJ; Ruedrich S
Lancet Neurol; 2022 Jan; 21(1):31-41. PubMed ID: 34942135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
